Rebecca Raabe

About

Rebecca Raabe brings two decades of operating, consulting, and investing experience in the medical technology sector to SPRIG Equity. Rebecca began her career as an operator, working in both public companies (Abbott) and private medical device companies, including Ulthera (acquired by Merz) and Cayenne Medical (acquired by Zimmer). She held leadership roles across strategy and commercialization. As an investor, Rebecca worked on Abbott’s corporate venture team, managing equity investments and helping develop new franchise strategies. She later joined Ballast Capital, evaluating transactions across the medtech landscape, and has also served as an advisor to Rx3 Growth Partners, an investment firm focused on growth-stage health and wellness consumer brands. Before co-founding SPRIG Equity, Rebecca was a consultant with SPRIG Consulting, a leading strategy and commercialization firm that specializes in partnering with private medical technology companies. She holds an MBA from Northwester

Source (opens in a new tab)